HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 16 filers reported holding HORIZON PHARMA PLC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $31,017,000 | +6.7% | 1,173,548 | -21.1% | 0.21% | -0.5% |
| Q4 2018 | $29,059,000 | -40.1% | 1,487,147 | -40.0% | 0.22% | -28.8% |
| Q3 2018 | $48,524,000 | +0.3% | 2,478,198 | -15.2% | 0.30% | -2.3% |
| Q2 2018 | $48,401,000 | -9.0% | 2,922,710 | -22.0% | 0.31% | -7.8% |
| Q1 2018 | $53,205,000 | -12.4% | 3,746,807 | -9.9% | 0.34% | -7.7% |
| Q4 2017 | $60,743,000 | +19.4% | 4,160,474 | +3.7% | 0.36% | +12.7% |
| Q3 2017 | $50,855,000 | +8.2% | 4,010,620 | +1.3% | 0.32% | +7.3% |
| Q2 2017 | $46,991,000 | -9.9% | 3,958,802 | +12.1% | 0.30% | -9.1% |
| Q1 2017 | $52,178,000 | +29.4% | 3,530,256 | +41.7% | 0.33% | +28.9% |
| Q4 2016 | $40,317,000 | -15.9% | 2,491,773 | -5.8% | 0.26% | -19.0% |
| Q3 2016 | $47,950,000 | +3.6% | 2,644,758 | -5.9% | 0.32% | +1.3% |
| Q2 2016 | $46,271,000 | +13.1% | 2,809,382 | +13.8% | 0.31% | +16.9% |
| Q1 2016 | $40,908,000 | -16.9% | 2,468,764 | +8.7% | 0.27% | -14.7% |
| Q4 2015 | $49,203,000 | – | 2,270,520 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 3,018,021 | $44,063,000 | 7.20% |
| SCOPIA CAPITAL MANAGEMENT LP | 16,370,364 | $239,007,000 | 4.29% |
| JW Asset Management, LLC | 270,775 | $3,953,000 | 4.21% |
| Avoro Capital Advisors LLC | 4,436,183 | $64,768,000 | 4.20% |
| Rhenman & Partners Asset Management AB | 1,954,912 | $28,542,000 | 3.86% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,341,894 | $92,592,000 | 3.64% |
| Paulson & Co. | 7,870,700 | $114,912,000 | 2.24% |
| Proxima Capital Management, LLC | 260,000 | $3,796,000 | 2.20% |
| KOPP INVESTMENT ADVISORS LLC | 105,126 | $1,535,000 | 1.54% |
| ARMISTICE CAPITAL, LLC | 1,000,000 | $14,600,000 | 1.46% |